secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sintx Technologies, Inc. (SINT)
CIK:        0001269026
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001641172-25-016891
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SINTX acquires SiNAPTIC Surgical assets for $750K in stock plus warrants; enters foot/ankle fusion market
--------------------------------------------------------------------------------

- Acquired all IP and designs for six foot/ankle implant systems; market valued at $750M growing to $1.38B by 2032.
- Consideration: $750K in common shares at $3.465 (10% premium) plus 325,000 performance-based warrants exercisable at $6.30.
- Warrants vest upon FDA clearance and cumulative revenue milestones up to $15M; also 5% royalty after $15M.
- Key SiNAPTIC executives join SINTX: Dr. Bryan Scheer leads Clinical Advisory Board, plus others in commercial and regulatory roles.
- Expected closing July 1, 2025; SINTX will manufacture under its existing FDA-registered and ISO-certified quality system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1269026/000164117225016891/0001641172-25-016891-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1269026/000164117225016891/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016891

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer